Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Establishment and Drug Sensitivity, Gene Expression and Epigenetic Characterization of a Pediatric Leukemia Cell Line (POETIC1) with Primary Resistance to Decitabine

Maneka Perinpanayagam, PhD, Anna Kovalchuk, Yibing Ruan, PhD, Sungmyung Kang, Aarthi Jayanthan, Olga Kovalchuk, Jessica Boklan, MD, Aru Narendran, MD PhD

Blood (2014) 124 (21): 983.

https://doi.org/10.1182/blood.V124.21.983.983

Published: 2014

Journal Articles

Whole Exome Sequencing Reveals Clonal Evolution Pattern and Driver Mutations Of Relapsed Pediatric AML

Kenichi Yoshida, MD, Norio Shiba, MD, PhD, Yuichi Shiraishi, PhD, Akira Shimada, MD., PhD, Kiminori Terui, MD, PhD, Motohiro Kato, MD, PhD, Yusuke Okuno, MD, PhD, Yasunobu Nagata, MD, Ayana Kon, MD, Tetsuichi Yoshizato, MD, Manabu Matsunawa, MD, Kenichi Chiba, BA, Hiroko Tanaka, BA, Masashi Sanada, MD, Satoru Miyano, PhD, Etsuro Ito, MD, PhD, Yasuhide Hayashi, MD, PhD, Seishi Ogawa, MD, PhD

Blood (2013) 122 (21): 1410.

https://doi.org/10.1182/blood.V122.21.1410.1410

Published: 2013

Journal Articles

Frequency and Prognostic Relevance of Gene Mutations in Pediatric AML Patients At First Relapse.

Costa Bachas, MSc, Gerrit Jan Schuurhuis, PhD, Dirk Reinhardt, MD, Ursula Creutzig, MD, PhD, Zinia J. Kwidama, BSc, C. Michel Zwaan, MD, PhD, Marry M. van den Heuvel-Eibrink, Evelina S De Bont, MD, PhD, Sara Elitzur, MD, Carmelo Rizzari, MD, PhD, Valérie de Haas, MD, PhD, Martin Zimmermann, Jacqueline Cloos, PhD, Gertjan J.L. Kaspers, MD, PhD

Blood (2012) 120 (21): 2480.

https://doi.org/10.1182/blood.V120.21.2480.2480

Published: 2012

Journal Articles

Genome Wide Promoter Methylation Patterns Predict AML Subtype Outcomes and Identify Novel Pathways Characterizing Diagnostic and Relapsed Disease in Children

Michael Ochs, Ph.D., Jason Farrar, M.D., Michael Considine, M.S., Rhonda E. Ries, MA, Lisa R. Trevino, PhD, Todd A. Alonzo, PhD, Jaime Guidry-Auvil, Ph.D., Tanja M. Davidsen, PhD, Patee Gesuwan, Ph.D., Donna M. Muzny, Alan S. Gamis, MD, MPH, David A. Wheeler, PhD, Heather L. Helton, MD, Malcolm A. Smith, MD, PhD, Daniela S. Gerhard, Ph.D., Soheil Meshinchi, MD, PhD, Robert J. Arceci, MD, PhD

Blood (2012) 120 (21): 1287.

https://doi.org/10.1182/blood.V120.21.1287.1287

Published: 2012

Journal Articles

Large Interindividual Differences in In Vitro Calicheamicin Sensitivity May Underly Gemtuzumab Ozogamicin Resistance in Acute Myeloid Leukemia (AML).

Bianca F. Goemans, MD, Gertjan J.L. Kaspers, MD, PhD, Susanne J.H. Vijverberg, BSc, Anne H. Loonen, Ursula Creutzig, MD, PhD, Karel Hahlen, MD, PhD, Dirk Reinhardt, MD, PhD, Brenda E.S. Gibson, MD, PhD, Jacqueline Cloos, PhD, Christian M. Zwaan, MD, PhD

Blood (2005) 106 (11): 107.

https://doi.org/10.1182/blood.V106.11.107.107

Published: 2005

Journal Articles

In-Vitro Cytotoxicity of Tipifarnib (Zarnestra TM) in Pediatric AML and ALL Samples Is Independent of RAS Mutations.

Bianca F. Goemans, MD, Christian M. Zwaan, MD, PhD, Gertjan J.L. Kaspers, MD, PhD, Karel Hählen, MD, Dirk Reinhardt, MD, PhD, Ursula Creutzig, MD, PhD, Michael C. Heinrich, MD

Blood (2004) 104 (11): 1172.

https://doi.org/10.1182/blood.V104.11.1172.1172

Published: 2004

Journal Articles

FLT3/Internal Tandem Duplication in Paired Presentation and Relapse Pediatric AML Samples.

Jacqueline Cloos, PhD, Christian M. Zwaan, MD, PhD, Sophie L. Corthals, Bianca F. Goemans, MD, Quinten Waisfisz, PhD, Ursula Creutzig, MD, PhD, Dirk Reinhardt, MD, PhD, Karel Hählen, MD, PhD, Gertjan J.L. Kaspers, MD, PhD

Blood (2004) 104 (11): 94.

https://doi.org/10.1182/blood.V104.11.94.94

Published: 2004

NARROW

Establishment and Drug Sensitivity, Gene Expression and Epigenetic Characterization of a Pediatric Leukemia Cell Line (POETIC1) with Primary Resistance to Decitabine

Whole Exome Sequencing Reveals Clonal Evolution Pattern and Driver Mutations Of Relapsed Pediatric AML

Frequency and Prognostic Relevance of Gene Mutations in Pediatric AML Patients At First Relapse.

Genome Wide Promoter Methylation Patterns Predict AML Subtype Outcomes and Identify Novel Pathways Characterizing Diagnostic and Relapsed Disease in Children

Large Interindividual Differences in In Vitro Calicheamicin Sensitivity May Underly Gemtuzumab Ozogamicin Resistance in Acute Myeloid Leukemia (AML).

In-Vitro Cytotoxicity of Tipifarnib (Zarnestra TM) in Pediatric AML and ALL Samples Is Independent of RAS Mutations.

FLT3/Internal Tandem Duplication in Paired Presentation and Relapse Pediatric AML Samples.

Email alerts

ASH Publications

American Society of Hematology

Establishment and Drug Sensitivity, Gene Expression and Epigenetic Characterization of a Pediatric Leukemia Cell Line (POETIC1) with Primary Resistance to Decitabine

Whole Exome Sequencing Reveals Clonal Evolution Pattern and Driver Mutations Of Relapsed Pediatric AML

Frequency and Prognostic Relevance of Gene Mutations in Pediatric AML Patients At First Relapse.

Genome Wide Promoter Methylation Patterns Predict AML Subtype Outcomes and Identify Novel Pathways Characterizing Diagnostic and Relapsed Disease in Children

Large Interindividual Differences in In Vitro Calicheamicin Sensitivity May Underly Gemtuzumab Ozogamicin Resistance in Acute Myeloid Leukemia (AML).

In-Vitro Cytotoxicity of Tipifarnib (Zarnestra TM) in Pediatric AML and ALL Samples Is Independent of RAS Mutations.

FLT3/Internal Tandem Duplication in Paired Presentation and Relapse Pediatric AML Samples.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only